Trade Zynerba Pharmaceuticals, Inc. - ZYNE CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023401% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001179% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.25 |
| Open | 1.25 |
| 1-Year Change | 73.61% |
| Day's Range | 1.25 - 1.31 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Oct 10, 2023 | 1.29 | 0.05 | 4.03% | 1.24 | 1.31 | 1.24 |
| Oct 9, 2023 | 1.25 | 0.04 | 3.31% | 1.21 | 1.26 | 1.21 |
| Oct 6, 2023 | 1.25 | 0.05 | 4.17% | 1.20 | 1.25 | 1.20 |
| Oct 5, 2023 | 1.24 | 0.06 | 5.08% | 1.18 | 1.24 | 1.18 |
| Oct 4, 2023 | 1.19 | -0.04 | -3.25% | 1.23 | 1.24 | 1.16 |
| Oct 3, 2023 | 1.24 | 0.00 | 0.00% | 1.24 | 1.24 | 1.21 |
| Oct 2, 2023 | 1.24 | -0.01 | -0.80% | 1.25 | 1.25 | 1.23 |
| Sep 29, 2023 | 1.25 | -0.01 | -0.79% | 1.26 | 1.26 | 1.24 |
| Sep 28, 2023 | 1.26 | 0.01 | 0.80% | 1.25 | 1.26 | 1.25 |
| Sep 27, 2023 | 1.25 | 0.01 | 0.81% | 1.24 | 1.28 | 1.24 |
| Sep 26, 2023 | 1.26 | -0.04 | -3.08% | 1.30 | 1.31 | 1.25 |
| Sep 25, 2023 | 1.30 | 0.00 | 0.00% | 1.30 | 1.30 | 1.30 |
| Sep 22, 2023 | 1.31 | 0.01 | 0.77% | 1.30 | 1.32 | 1.30 |
| Sep 21, 2023 | 1.30 | -0.01 | -0.76% | 1.31 | 1.33 | 1.29 |
| Sep 20, 2023 | 1.33 | 0.03 | 2.31% | 1.30 | 1.34 | 1.30 |
| Sep 19, 2023 | 1.31 | 0.00 | 0.00% | 1.31 | 1.33 | 1.31 |
| Sep 18, 2023 | 1.31 | -0.02 | -1.50% | 1.33 | 1.34 | 1.31 |
| Sep 15, 2023 | 1.36 | 0.05 | 3.82% | 1.31 | 1.37 | 1.31 |
| Sep 14, 2023 | 1.32 | 0.02 | 1.54% | 1.30 | 1.32 | 1.30 |
| Sep 13, 2023 | 1.30 | 0.00 | 0.00% | 1.30 | 1.33 | 1.30 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Zynerba Pharmaceuticals, Inc.
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It improves the lives of patients and their families living with severe, chronic health conditions, including Fragile X syndrome, autism spectrum disorder, 22q11.2 deletion syndrome, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania.| Industry: | Biotechnology & Medical Research (NEC) |
80 W. Lancaster Avenue
Suite 300
DEVON
PENNSYLVANIA 19333
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com